» Articles » PMID: 27774001

The Significance of the Enteric Microbiome on the Development of Childhood Disease: A Review of Prebiotic and Probiotic Therapies in Disorders of Childhood

Overview
Publisher Sage Publications
Specialty Pediatrics
Date 2016 Oct 25
PMID 27774001
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Recent studies have highlighted the fact that the enteric microbiome, the trillions of microbes that inhabit the human digestive tract, has a significant effect on health and disease. Methods for manipulating the enteric microbiome, particularly through probiotics and microbial ecosystem transplantation, have undergone some study in clinical trials. We review some of the evidence for microbiome alteration in relation to childhood disease and discuss the clinical trials that have examined the manipulation of the microbiome in an effort to prevent or treat childhood disease with a primary focus on probiotics, prebiotics, and/or synbiotics (ie, probiotics + prebiotics). Studies show that alterations in the microbiome may be a consequence of events occurring during infancy and/or childhood such as prematurity, C-sections, and nosocomial infections. In addition, certain childhood diseases have been associated with microbiome alterations, namely necrotizing enterocolitis, infantile colic, asthma, atopic disease, gastrointestinal disease, diabetes, malnutrition, mood/anxiety disorders, and autism spectrum disorders. Treatment studies suggest that probiotics are potentially protective against the development of some of these diseases. Timing and duration of treatment, the optimal probiotic strain(s), and factors that may alter the composition and function of the microbiome are still in need of further research. Other treatments such as prebiotics, fecal microbial transplantation, and antibiotics have limited evidence. Future translational work, models, long-term and follow-up studies, and guidelines for the composition and viability of probiotic and microbial therapies need to be developed. Overall, there is promising evidence that manipulating the microbiome with probiotics early in life can help prevent or reduce the severity of some childhood diseases, but further research is needed to elucidate biological mechanisms and determine optimal treatments.

Citing Articles

Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and gut microbiota composition: what do we know?.

Tagi V, Tosi M, Greco I, Stucchi E, Verduci E, Zuccotti G Front Nutr. 2025; 11():1477893.

PMID: 39834450 PMC: 11743372. DOI: 10.3389/fnut.2024.1477893.


The Role of the Gut and Airway Microbiota in Chronic Rhinosinusitis with Nasal Polyps: A Systematic Review.

Gomez-Garcia M, Moreno-Jimenez E, Morgado N, Garcia-Sanchez A, Gil-Melcon M, Perez-Pazos J Int J Mol Sci. 2024; 25(15).

PMID: 39125792 PMC: 11311313. DOI: 10.3390/ijms25158223.


Three-arm clinical trial of improved flour targeting intestinal microbiota (MALINEA).

Vray M, Tondeur L, Hedible B, Randremanana R, Manirakiza A, Lazoumar R Matern Child Nutr. 2024; 20(3):e13649.

PMID: 38599819 PMC: 11168351. DOI: 10.1111/mcn.13649.


Liposomal Epigallocatechin-3-Gallate for the Treatment of Intestinal Dysbiosis in Children with Autism Spectrum Disorder: A Comprehensive Review.

de la Rubia Orti J, Moneti C, Serrano-Ballesteros P, Castellano G, Bayona-Babiloni R, Carriqui-Suarez A Nutrients. 2023; 15(14).

PMID: 37513683 PMC: 10383799. DOI: 10.3390/nu15143265.


Human microbiome and microbiota identification for preventing and controlling healthcare-associated infections: A systematic review.

Tozzo P, Delicati A, Caenazzo L Front Public Health. 2022; 10:989496.

PMID: 36530685 PMC: 9754121. DOI: 10.3389/fpubh.2022.989496.


References
1.
de Meij T, Budding A, de Groot E, Jansen F, Kneepkens C, Benninga M . Composition and stability of intestinal microbiota of healthy children within a Dutch population. FASEB J. 2015; 30(4):1512-22. DOI: 10.1096/fj.15-278622. View

2.
Hill D, Siracusa M, Abt M, Kim B, Kobuley D, Kubo M . Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation. Nat Med. 2012; 18(4):538-46. PMC: 3321082. DOI: 10.1038/nm.2657. View

3.
Mellon A, Deshpande S, Mathers J, Bartlett K . Effect of oral antibiotics on intestinal production of propionic acid. Arch Dis Child. 2000; 82(2):169-72. PMC: 1718213. DOI: 10.1136/adc.82.2.169. View

4.
Quera R, Espinoza R, Estay C, Rivera D . Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn's disease and recurrent Clostridium difficile infection. J Crohns Colitis. 2013; 8(3):252-3. DOI: 10.1016/j.crohns.2013.10.002. View

5.
DHaens G, Vermeire S, Van Assche G, Noman M, Aerden I, Van Olmen G . Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial. Gastroenterology. 2008; 135(4):1123-9. DOI: 10.1053/j.gastro.2008.07.010. View